For these herbs, there are anecdotal reports of efficacy which may be due to placebo effect. Scientific evidence for the efficacy of herbal galactagogues is insufficient or nonexistent. The Academy of Breastfeeding Medicine protocol for low milk supply says that there is insufficient data to recommend specific medicinal or herbal galactagogues, but that some substances may be useful in some cases.A Cochrane review showed that, despite the relatively large number of randomised controlled trials investigating medical and natural galactogogues, it is uncertain whether galactogogues have any effect on breastfeeding rates. Supplementary feeding
If the mothers milk supply is insufficient, formula or (preferably) donor milk is necessary in order for the infant to obtain adequate nutrients. Supplements should be given immediately after a breastfeeding session, rather than in place of a breastfeeding session.The use of supplements is gradually tapered off as the mothers own milk supply rebounds. In some cases, especially when low supply is caused by medical conditions such as insufficient glandular tissue, long-term use of supplements is necessary. For mothers who cannot breastfeed exclusively, breastfeeding as much as possible, with formula feeding as necessary, offers many benefits over formula alone. See also
Breastfeeding difficulties
Lactation

References
Bibliography
Lawrence, Ruth (2016). Breastfeeding : a guide for the medical profession, 8th edition. Philadelphia, PA: Elsevier. ISBN 978-0-323-35776-0.
DTaP-IPV/Hib vaccine is a 5-in-1 combination vaccine that protects against diphtheria, tetanus, whooping cough, polio, and Haemophilus influenzae type B.Its generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and haemophilus B conjugate vaccine, and it is also known as DTaP-IPV-Hib. Uses
DTaP-IPV/Hib vaccine is administered to young children to immunise against diphtheria, tetanus, pertussis, poliomyelitis, and diseases caused by Haemophilus influenzae type B.

Formulations
A branded formulation marketed in the United States is Pentacel, manufactured by Sanofi Pasteur.Pentacel is known in the UK and Canada as Pediacel.An equivalent vaccine marketed in the UK and Canada by GlaxoSmithKline is Infanrix IPV + Hib. This is a two-part vaccine. The DTaP-IPV component is supplied as a sterile liquid, which is used to reconstitute lyophilized (freeze-dried) Hib vaccine. Pentaxim is a liquid formulation marketed by Sanofi Pasteur. Availability
It is only licensed for young children. In the US the FDA have approved the vaccine for children from age 6 weeks up to age 5 years. It was used in the UK until 2017, following which a 6-in-1 vaccine became available containing the additional protection against Hepatitis B. == References ==